Melanie Oakes

Dr. Melanie Oakes

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GQGuangrong Qin
Guangrong Qin
JDJin Dai
Jin Dai
SCSylvia Chien
Sylvia Chien
TMTimothy J. Martins
Timothy J. Martins
BLBrenda Loera
Brenda Loera
PBPamela S. Becker
Pamela S. Becker
Purpose: The inherent genetic heterogeneity of acute myeloid leukemia (AML) has challenged the development of precise and effective therapies. The objective of this study was to elucidate the genomic basis of drug resistance or sensitivity, identify signatures for drug response prediction, and provide resources to the research community. Experimental Design: We performed targeted sequencing, high-throughput drug screening, and single-cell genomic profiling on leukemia cell samples derived from patients with AML. Statistical approaches and machine learning models were applied to identify signatures for drug response prediction. We also integrated large public datasets to understand the co-occurring mutation patterns and further investigated the mutation profiles in the single cells. The features revealed in the co-occurring or mutual exclusivity pattern were further subjected to machine learning models. Results: We detected genetic signatures associated with sensitivity or resistance to specific agents, and identified five co-occurring mutation groups. The application of single-cell genomic sequencing unveiled the co-occurrence of variants at the individual cell level, highlighting the presence of distinct subclones within patients with AML. Using the mutation pattern for drug response prediction demonstrates high accuracy in predicting sensitivity to some drug classes, such as MEK inhibitors for RAS-mutated leukemia. Conclusions: Our study highlights the importance of considering the gene mutation patterns for the prediction of drug response in AML. It provides a framework for categorizing patients with AML by mutations that enable drug sensitivity prediction.

9 August 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
AGAshley Green
Ashley Green
APAiswarya Rani Pappu
Aiswarya Rani Pappu
MOMelanie Oakes
Melanie Oakes
SSSuzanne Sandmeyer
Suzanne Sandmeyer
MHMatthew Hileman
Matthew Hileman
Sunny JiangSunny Jiang
Sunny Jiang
Wastewater can serve as both a source of pathogens that pose risks to human health and a valuable resource for tracking and predicting disease prevalence through wastewater-based surveillance (WBS). In WBS for SARS-CoV-2, both nucleocapsid-specific (N1 and N2) and the envelope (E) genes are common targets for primer design, but ambiguity remains regarding differences in results depending on the gene target chosen. This study investigated how and why two SARS-CoV-2 gene targets (N2 and E) varied when analyzed in a multiplex RT-ddPCR assay for a COVID-19 wastewater monitoring study. From December 2021 to June 2022, over 700 raw wastewater samples were collected from thirteen manholes in the University of California, Irvine sewer system. Murine hepatitis virus (MHV) was used as a matrix recovery and process control in the triplex RT-ddPCR assay. Water quality tests (TSS, COD, pH, turbidity and NH3-N) were performed on all samples. Analyses showed that in over 10% of samples, the E gene concentration exceeded N2 by more than one order of magnitude. To evaluate matrix effects on amplification efficiency for N2 and E genes, multiple regression analysis was performed to explore whether water quality variables and MHV recovery efficiency could predict variance in gene concentrations, but no clear relationship was identified. However, viral recovery, as indicated by MHV recovery efficiency, was negatively impacted in samples with higher TSS and COD, suggesting PCR inhibition. These findings contribute to methodological standardization efforts in WBS and emphasize the importance of primer selection for large-scale monitoring.

14 June 2024
Verified
Other
Open access
GQGuangrong Qin
Guangrong Qin
JDJin Dai
Jin Dai
SCSylvia Chien
Sylvia Chien
TMTimothy J. Martins
Timothy J. Martins
BLBrenda Loera
Brenda Loera
PBPamela S. Becker
Pamela S. Becker
Supplementary Table S1-S14 from Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia

14 June 2024
Verified
Other
Open access
GQGuangrong Qin
Guangrong Qin
JDJin Dai
Jin Dai
SCSylvia Chien
Sylvia Chien
TMTimothy J. Martins
Timothy J. Martins
BLBrenda Loera
Brenda Loera
PBPamela S. Becker
Pamela S. Becker
Purpose:The inherent genetic heterogeneity of acute myeloid leukemia (AML) has challenged the development of precise and effective therapies. The objective of this study was to elucidate the genomic basis of drug resistance or sensitivity, identify signatures for drug response prediction, and provide resources to the research community.Experimental Design:We performed targeted sequencing, high-throughput drug screening, and single-cell genomic profiling on leukemia cell samples derived from patients with AML. Statistical approaches and machine learning models were applied to identify signatures for drug response prediction. We also integrated large public datasets to understand the co-occurring mutation patterns and further investigated the mutation profiles in the single cells. The features revealed in the co-occurring or mutual exclusivity pattern were further subjected to machine learning models.Results:We detected genetic signatures associated with sensitivity or resistance to specific agents, and identified five co-occurring mutation groups. The application of single-cell genomic sequencing unveiled the co-occurrence of variants at the individual cell level, highlighting the presence of distinct subclones within patients with AML. Using the mutation pattern for drug response prediction demonstrates high accuracy in predicting sensitivity to some drug classes, such as MEK inhibitors for RAS-mutated leukemia.Conclusions:Our study highlights the importance of considering the gene mutation patterns for the prediction of drug response in AML. It provides a framework for categorizing patients with AML by mutations that enable drug sensitivity prediction.

14 June 2024
Verified
Other
Open access
GQGuangrong Qin
Guangrong Qin
JDJin Dai
Jin Dai
SCSylvia Chien
Sylvia Chien
TMTimothy J. Martins
Timothy J. Martins
BLBrenda Loera
Brenda Loera
PBPamela S. Becker
Pamela S. Becker
Supplementary Table S1-S14 from Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia